| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | ADVIA Centaur HBsAgII (HBsII) and ADVIA Centaur HBsAgII Confirmatory (HBsII Conf) Assay |
| Generic Name | Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) |
| Regulation Number | 866.3172 |
| Applicant | Siemens Corp. 511 Benedict Ave. Tarrytown, NY 10591 |
| PMA Number | P110041 |
| Supplement Number | S015 |
| Date Received | 09/13/2024 |
| Decision Date | 03/04/2025 |
| Reclassified Date | 10/20/2025 |
| Product Code |
LOM |
| Advisory Committee |
Microbiology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Change Design/Components/Specifications/Material |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for migration of the ADVIA Centaur HBsAg II (HBsII) and the ADVIA Centaur HBsAg Confirmatory (Conf) Assay, and the HBsAg II Quality Control (HBsII QC) onto the Atellica CI analyzer, which will be known as the Atellica IM HBsAg II (HBsII) and Atellica IM HBsAg II Confirmatory (HBsII Conf) Assay. |
|
|